The effects of quinine and artesunate treatment on plasma tumor necrosis factor levels in malaria-infected patients

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 30, Issue 1, 1999, Pages 7-10

  Ittarat, Wanida ^a,b   Udomsangpetch, Rachanee ^a   Chotivanich, Kesinee T ^a   Looareesuwan, Sornchai ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ARTESUNATE; QUININE; SESQUITERPENE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD; CELL ADHESION; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG MONITORING; FEMALE; HUMAN; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MALARIA FALCIPARUM; MALE; METHODOLOGY; MIDDLE AGED; PARASITOLOGY; RANDOMIZED CONTROLLED TRIAL; TIME; TREATMENT OUTCOME;

ADULT; ANTIMALARIALS; ARTEMISININS; CELL ADHESION; DRUG MONITORING; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; QUININE; SESQUITERPENES; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033084756     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Baptista JL, Vanham G, Wery M, Van Marck E. Cytokine levels during mild and cerebral falciparum malaria in children living in a mesoendemic area. Trop Med Int Health 1997; 2: 673-9.
2. de Kossodo S, Houba V, Grau GE. Assaying tumor necrosis factor concentrations in human serum. A WHO International Collaborative Study. J Immunol Methods 1995; 182: 107-4.
3. Grau GE, Taylor TE, Molyneux ME, et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 1989; 320: 1586-91.
4. Jakobsen PH, Bate CA, Taverne J, Playfair JH. Malaria: toxins, cytokines and disease. Parasite Immunol 1995; 17: 223-31.
5. Jeong JY, Jue DM. Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide-stimulated RAW 264.7 macrophages. J Immunol 1997; 158: 4901-7.
6. Kremsner PG, Winkler S, Brandts C, et al. Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production. Am J Trop Med Hyg 1995; 53: 532-8.
7. Kwiatkowski D, Cannon JG, Manogue KR, et al. Tumor necrosis factor production in falciparum malaria and its association with schizont rupture. Clin Exp Immunol 1989; 77: 361-6.
8. Kwiatkowski D, Clive B. Inhibition of tumor necrosis factor (TNF) production by antimalarial drugs used in cerebral malaria. Trans R Soc Trop Med Hyg 1995; 89: 215-6.
9. March K, English M, Crawley J, et al. The pathogenesis of severe malaria in African children. Ann Trop Med Parasitol 1996; 90: 395-402.
10. Medana IM, Hunt NH, Chaudhri G. Tumor necrosis factor-alpha expression in the brain during fatal murine cerebral malaria: evidence for production by microglia and astrocytes. Am J Pathol 1997; 150: 1473-86.
11. Picot S, Peyron F, Donadille A, et al. Chloroquine-induced inhibition of the production of TNF, but not of IL-6, is affected by disruption of iron metabolism. Immunology 1993; 80: 127-33.
12. Picot S, Nkwelle Akede A, Chaulet J-F, et al. Chloroquine self-treatment and clinical outcome of cerebral malaria in children. Clin Exp Immunol 1997; 108: 279-3.
13. Richards AL. Tumour necrosis factor and associated cytokines in the host's response to malaria. Int J Parasitol 1997; 27: 1251-63.
14. Turner G. Cerebral malaria. Brain Pathol 1997; 7: 569-82.
15. Udomsangpetch R, Pipitaporn B, Krishna S, et al. Antimalarial drugs reduce cytoadherence and rosetting Plasmodium falciparum. J Infect Dis 1996; 173: 691-8.
16. Warrell DA. The 1996 Runme Shaw Memorial Lecture: malaria-past, present and future. Ann Acad Med Singapore 1997; 26: 380-7.